RxDoctor Payments Data

Arthur Saari

Pulmonary Disease · Marquette, MINPI 1477651891

Payments from drug & device makers

$2,562in general payments, 2019–2025

Across 175 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$697
  • GSK$653
  • Sanofi$336
  • Boehringer Ingelheim$208
  • Grifols USA, LLC$151
  • Insmed, Inc.$110
  • plus $408 from 10 others

What the payments were for

  • Food & beverage$2,47397%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,562 in reported general payments places this provider in the 55th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Marquette

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →